Author: Amanda Moore
-

Quick answer: Blood clots after CRS/HIPEC are more common than many patients are told. In a large study of people treated for pseudomyxoma peritonei, about 1 in 9 had a clot in the first couple of weeks. Most leg clots caused no symptoms, and a lung clot can happen even when your legs feel fine.…
-

Amy Moeller was diagnosed with appendix cancer at 38 and lived well for eleven years before an appendix cancer recurrence showed up on a routine colonoscopy. She is now on a CDK4/6 inhibitor called Ibrance, and she is doing well again. About a year ago, I typed appendix cancer into the LinkedIn search bar, and…
-

Short answer: Prehab before surgery means getting your body and mind ready in the weeks before a big operation. For appendix cancer patients facing cytoreductive surgery with HIPEC, that preparation is linked to fewer complications and an easier recovery. So many people spend the days before surgery just waiting. Waiting for the date, the scans,…
-

Researchers have identified the LGR5/Wnt pathway as a possible treatment target in goblet cell adenocarcinoma, a rare appendix cancer. The finding comes from a 2026 Cancer Research conference abstract that analyzed these tumors’ genes and gene activity. No drug was tested in patients. I hear from families who are told there is no targeted treatment…
-

A new lab study on RAS-driven cancers is getting attention, and it matters for appendix cancer research even though it did not test a single appendix tumor. The results look promising in mice, but they are early, and appendix cancer research still needs its own data before anyone can say what this means for patients.…
